(Q42919329)

English

Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats

scientific article published on September 9, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

H. Kalonia

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20813166

5 July 2024

P. Kumar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20813166

5 July 2024

A. Kumar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20813166

5 July 2024

B. Nehru

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20813166

5 July 2024

language of work or name

0 references

publication date

9 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S030645221001167X?httpAccept=text/xml

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

https://api.elsevier.com/content/article/PII:S030645221001167X?httpAccept=text/plain

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

171

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

284-299

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients.

1

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.

2

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes

3

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

4

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.

5

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice

6

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.

7

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons.

8

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS.

9

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Montelukast sodium for exercise-induced asthma

10

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats

11

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation

12

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway.

13

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

15

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?

16

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Role of TNF receptor-associated factor 3 in the CD40 signaling by production of reactive oxygen species through association with p40phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase

17

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats.

18

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats

19

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

22

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase

23

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity

25

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms

26

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Activated immune system in patients with Huntington's disease

27

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Cytokines, chemokines, and cytokine receptors in human microglia

28

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway.

29

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

30

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions

32

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice

33

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration

34

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid

36

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease

37

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease

38

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats

39

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity

40

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.

41

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

The neurotoxicity of excitatory amino acids is produced by passive chloride influx

42

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

43

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease

44

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Calcium Dependence of Toxic Cell Death: A Final Common Pathway

45

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

II. Excitotoxic models for neurodegenerative disorders

46

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.

47

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine

48

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease

49

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study

50

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation

51

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Prostaglandins and cyclooxygenases in glial cells during brain inflammation

52

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.

53

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

54

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease

55

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Mechanisms of lipid peroxide formation in animal tissues

56

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice

57

1 reference

10.1016/J.NEUROSCIENCE.2010.08.039

https://api.crossref.org/works/10.1016/J.NEUROSCIENCE.2010.08.039

5 July 2024

Identifiers

10.1016/J.NEUROSCIENCE.2010.08.039

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42919329&oldid=2196221412"